Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Meeting Report
  • Published:

Breaking down the barriers to cancer immunotherapy

Nature Immunology volume 6, pages 1207–1210 (2005)Cite this article

Abstract

Emerging insights into the mechanisms of activation and negative regulation of innate and adaptive immune cells are providing new opportunities for the development of safe and effective cancer vaccines.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Innate and adaptive immune cell mediated tumoricidal activities.
Figure 2: Opportunities for adaptive immunotherapy and cancer vaccines.

References

  1. Old, L.J. & Boyse, E.A. Annu. Rev. Med. 15, 167–186 (1964).

    Article  CAS  Google Scholar 

  2. Stutman, O. Science 183, 534–536 (1974).

    Article  CAS  Google Scholar 

  3. Kaplan, D.H. et al. Proc. Natl. Acad. Sci. USA 95, 7556–7561 (1998).

    Article  CAS  Google Scholar 

  4. Shankaran, V. et al. Nature 410, 1107–1111 (2001).

    Article  CAS  Google Scholar 

  5. Dunn, G.P., Old, L.J. & Schreiber, R.D. Annu. Rev. Immunol. 22, 329–360 (2004).

    Article  CAS  Google Scholar 

  6. van den Broek, M.E. et al. J Exp Med. 184, 1781–1790 (1996).

    Article  CAS  Google Scholar 

  7. Street, S.E., Trapani, J.A., MacGregor, D. & Smyth, M.J. J. Exp. Med. 196, 129–134 (2002).

    Article  CAS  Google Scholar 

  8. Smyth, M.J. et al. J. Exp. Med. 192, 775–760 (2000).

    Article  Google Scholar 

  9. Clementi, R. et al. Blood 105, 4424–4428 (2005).

    Article  CAS  Google Scholar 

  10. Bartkova, J. et al. Nature 434, 864–870 (2005).

    Article  CAS  Google Scholar 

  11. Egen, J.G., Kuhns, M.S. & Allison, J.P. Nat. Immunol. 3, 611–618 (2002).

    Article  CAS  Google Scholar 

  12. Chambers, C.A., Kuhns, M.S., Egen, J.G. & Allison, J.P. Annu. Rev. Immunol. 19, 565–594 (2001).

    Article  CAS  Google Scholar 

  13. Dudley, M.E. et al. J. Clin. Oncol. 23, 2346–2357 (2005).

    Article  CAS  Google Scholar 

  14. Old, L.J. Cancer Immunology 1, 1 (2001).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wistar Institute and The Ludwig Institute for Cancer, Philadelphia, 19104, Pennsylvania, USA

    Ellen Puré

  2. Memorial Sloan-Kettering Cancer Center, New York, 10021, New York, USA

    James P Allison

  3. Washington University School of Medicine, St. Louis, 63110, Missouri, USA

    Robert D Schreiber

Authors
  1. Ellen Puré
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James P Allison
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert D Schreiber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ellen Puré.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Puré, E., Allison, J. & Schreiber, R. Breaking down the barriers to cancer immunotherapy. Nat Immunol 6, 1207–1210 (2005). https://doi.org/10.1038/ni1205-1207

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni1205-1207

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing